World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
86
Citations
32746
World Ranking
13962
National Ranking
460

Overview

Jeff Szer is a researcher affiliated with the Peter MacCallum Cancer Centre in Australia. Their scholarly work is concentrated within the field of Medicine, with particular emphasis on Hematology, Immunology, and Genetics. The subfields that feature prominently in their research include Physiology and Public Health, Environmental and Occupational Health.

The main topics addressed in their publications reflect a focus on blood and immune system-related medical issues. These topics include:

  • Complement system in diseases
  • Hematopoietic Stem Cell Transplantation
  • Blood groups and transfusion
  • Coagulation, Bradykinin, Polyphosphates, and Angioedema
  • Acute Myeloid Leukemia Research
  • Lysosomal Storage Disorders Research
  • Renal Diseases and Glomerulopathies

Jeff Szer has contributed to a variety of scientific articles across multiple respected journals. Frequent publication venues for their work include:

  • Internal Medicine Journal
  • Blood
  • Haematologica
  • The Lancet Haematology
  • Bone Marrow Transplantation

Their recent papers cover notable studies in the areas of hematology and treatment of blood-related diseases, including:

  • "Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease", 2020, New England Journal of Medicine
  • "Pegcetacoplan versus Eculizumab in Paroxysmal Nocturnal Hemoglobinuria", 2021, New England Journal of Medicine
  • "One and a half million hematopoietic stem cell transplants: continuous and differential improvement in worldwide access with the use of non-identical family donors", 2021, Haematologica
  • "Managing haematology and oncology patients during the COVID-19 pandemic: interim consensus guidance", 2020, The Medical Journal of Australia
  • "Characterization of breakthrough hemolysis events observed in the phase 3 randomized studies of ravulizumab versus eculizumab in adults with paroxysmal nocturnal hemoglobinuria", 2020, Haematologica

The researcher frequently collaborates with other scientists, with the most common coauthors being:

  • Régis Peffault de Latour
  • Mahmoud Aljurf
  • Morag Griffin
  • Dietger Niederwieser
  • Mickey Koh

Best Publications

  • The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria.

    Peter Hillmen;Neal S. Young;Jörg Schubert;Robert A. Brodsky

  • Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy

    W.P. Sheridan;R.M. Fox;C.G. Begley;D. Maher

  • Detection of BCR-ABL mutations in patients with CML treated with imatinib is virtually always accompanied by clinical resistance, and mutations in the ATP phosphate-binding loop (P-loop) are associated with a poor prognosis

    Susan Branford;Zbigniew Rudzki;Sonya Walsh;Ian Parkinson

  • Hematopoietic stem cell transplantation: a global perspective

    Alois Gratwohl;Helen Baldomero;Mahmoud Aljurf;Marcelo C. Pasquini

  • Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease

    Robert Zeiser;Nikolas von Bubnoff;Jason Butler;Mohamad Mohty

  • Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria.

    Peter Hillmen;Petra Muus;Ulrich Dührsen;Antonio M. Risitano

  • Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation

    Navneet S. Majhail;Navneet S. Majhail;J. Douglas Rizzo;Stephanie J. Lee;Mahmoud Aljurf

  • A randomized study of high-dose cytarabine in induction in acute myeloid leukemia.

    JF Bishop;JP Matthews;Ga Young;J Szer

  • A No-Prophylaxis Platelet-Transfusion Strategy for Hematologic Cancers

    Simon J Stanworth;Lise J Estcourt;Lise J Estcourt;Gillian Powter;Brennan C Kahan

  • One million haemopoietic stem-cell transplants: a retrospective observational study

    Alois Gratwohl;Marcelo C Pasquini;Mahmoud Aljurf;Yoshiko Atsuta

  • Long-term safety and efficacy of sustained eculizumab treatment in patients with paroxysmal nocturnal haemoglobinuria

    Peter Hillmen;Petra Muus;Alexander Roth;Modupe O. Elebute

  • A Randomized, Double-Blind, Placebo-Controlled, Phase III Study of Filgrastim in Remission Induction and Consolidation Therapy for Adults With De Novo Acute Myeloid Leukemia

    Gerhard Heil;Dieter Hoelzer;Miguel A. Sanz;Klaus Lechner

  • Hematopoietic stem cell transplantation activity worldwide in 2012 and a SWOT analysis of the Worldwide Network for Blood and Marrow Transplantation Group including the global survey

    Dietger Niederwieser;Helen Baldomero;Jeff Szer;Michael Gratwohl

  • All-trans-retinoic acid, idarubicin, and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia (APML4)

    Harry J. Iland;Harry J. Iland;Ken Bradstock;Ken Bradstock;Shane G. Supple;Alberto Catalano

  • Improved leukemia-free survival after postconsolidation immunotherapy with histamine dihydrochloride and interleukin-2 in acute myeloid leukemia: results of a randomized phase 3 trial.

    Mats Brune;Sylvie Castaigne;John Catalano;Kurt Gehlsen

  • Prospective, Randomized, Double-Blind, Phase III Clinical Trial of Anti-T-Lymphocyte Globulin to Assess Impact on Chronic Graft-Versus-Host Disease-Free Survival in Patients Undergoing HLA-Matched Unrelated Myeloablative Hematopoietic Cell Transplantation.

    Robert J. Soiffer;Haesook T. Kim;Joseph McGuirk;Mitchell E. Horwitz

  • Ravulizumab (ALXN1210) vs eculizumab in C5-inhibitor-experienced adult patients with PNH: the 302 study.

    Austin G. Kulasekararaj;Anita Hill;Scott T. Rottinghaus;Saskia Langemeijer

  • Deletions of the derivative chromosome 9 occur at the time of the Philadelphia translocation and provide a powerful and independent prognostic indicator in chronic myeloid leukemia

    Brian J P Huntly;Alistair G Reid;Anthony J Bench;L J Campbell

  • Transplantation of mobilized peripheral blood cells to HLA-identical siblings with standard-risk leukemia.

    Norbert Schmitz;Meral Beksac;Dirk Hasenclever;Andrea Bacigalupo

  • Effect of peripheral blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy.

    A Grigg;C G Begley;C A Juttner;J Szer

Frequent Co-Authors

David Ritchie
David Ritchie Peter MacCallum Cancer Centre
Andrew Grigg
Andrew Grigg Austin Hospital
Kenneth F. Bradstock
Kenneth F. Bradstock Westmead Hospital
Mahmoud Aljurf
Mahmoud Aljurf King Faisal Specialist Hospital & Research Centre
John F. Seymour
John F. Seymour Peter MacCallum Cancer Centre
Andrew W. Roberts
Andrew W. Roberts Walter and Eliza Hall Institute of Medical Research
Monica A. Slavin
Monica A. Slavin Peter MacCallum Cancer Centre
Daniel J. Weisdorf
Daniel J. Weisdorf University of Minnesota
Hubert Schrezenmeier
Hubert Schrezenmeier University of Ulm
Mary M. Horowitz
Mary M. Horowitz Medical College of Wisconsin

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in medicine but looking for a more flexible or alternative career path, many accredited online degrees offer expanded opportunities in healthcare. For those who prefer administrative roles, exploring the medical billing and coding schools online can provide a streamlined route into healthcare systems with the potential for remote work and career growth.

Nursing also remains a highly in-demand field. If you want to advance without traditional entrance exams, consider lpn to rn programs without teas test requirements to continue your educational journey. For those aspiring to move into leadership, the best online healthcare administration degree programs prepare graduates for management and executive positions within hospitals and clinics.

Registered nurses aiming for advanced practice should explore rn to fnp bridge programs, which enable a focused transition to becoming a Family Nurse Practitioner. These online pathways provide flexible options to earn qualifications while balancing work and family life.

Best Scientists Citing Jeff Szer

Trending Scientists

Recently Published Articles